DXCM SHAREHOLDER NEWS: BFA Law is Investigating DexCom, Inc. for Securities Fraud - Investors that Lost Money are Urged to Contact the Firm to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / August 3, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ:DXCM) for potential violations of the federal securities laws. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Recently, weight loss and diabetes watch company DexCom Inc. NASDAQ: DXCM stock plummeted by over 44% on a surprisingly bad quarterly earnings report. Management guided lower – much lower – than analysts had expected to see revenue and earnings per share (EPS), and it all had to do with the decreasing demand for the company's medical devices, which are being replaced more and more by effective medicine lately.
DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About "Disruptive" Sales Force Expansion, Shares Plummet - Hagens Berman
SAN FRANCISCO, CA / ACCESSWIRE / August 2, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
DexCom, Inc. Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
RADNOR, PA / ACCESSWIRE / August 2, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DexCom, Inc. (NASDAQ:DXCM) ("DexCom"). On July 25, 2024, after the market closed, DexCom announced disappointing earnings results for its second quarter of 2024 and slashed full year revenue guidance from $4.35 billion to $4 billion-$4.05 billion.
An Investigation Has Commenced on Behalf of DexCom, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your DXCM Losses.
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federal securities laws. After the closure of market trading, on July 25, 2024, DexCom issued a press release announcing its financial results for the second quarter of 2024.
DexCom, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - DXCM
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federal securities laws. After the closure of market trading, on July 25, 2024, DexCom issued a press release announcing its financial results for the second quarter of 2024.
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into DexCom, Inc. and Encourages Shareholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM). Investors who purchased DexCom securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DXCM.
DexCom, Inc. (DXCM) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federal securities laws. After the closure of market trading, on July 25, 2024, DexCom issued a press release announcing its financial results for the second quarter of 2024.
ATTENTION DexCom, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federal securities laws. After the closure of market trading, on July 25, 2024, DexCom issued a press release announcing its financial results for the second quarter of 2024.
DXCM STOCK ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federal securities laws. After the closure of market trading, on July 25, 2024, DexCom issued a press release announcing its financial results for the second quarter of 2024.
DXCM INVESTOR NOTICE: DexCom, Inc. (DXCM) is being Investigated for Securities Fraud by BFA Law; Shareholders that Lost Money are Urged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ:DXCM) for potential violations of the federal securities laws. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here
DXCM ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by DexCom, Inc.
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federal securities laws. After the closure of market trading, on July 25, 2024, DexCom issued a press release announcing its financial results for the second quarter of 2024.
